Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions

CompletedOBSERVATIONAL
Enrollment

199

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

August 31, 2013

Conditions
Peripheral Arterial DiseaseCritical Limb Ischemia
Interventions
DEVICE

Retrograde tibiopedal arterial access

Retrograde, percutaneous arterial access of vessels at or below the tibioperoneal trunk, using a 21 gage needle or micropuncture introducer set, to facilitate crossing and treatment (e.g., angioplasty, stenting, atherectomy) of occlusive arterial lesions in the lower limb.

Trial Locations (11)

20010

MedStar Health Research Institute (Washington Hospital Center), Washington D.C.

25304

CAMC Health Education and Research Institute, Inc., Charleston

27607

Rex Hospital, Inc, Raleigh

32216

First Coast Cardiovascular Institute, Jacksonville

33140

University of Miami (Mount Sinai Hospital), Miami

35031

Casa Di Cura Abano Terme, Abano Terme

49519

Metro Heart and Vascular, Wyoming

70360

Terrebone Medical Center, Houma

79189

Universit ts-Herzzentrum Freiburg - Bad Krozingen GmbH, Bad Krozingen

85712

Interventional Technologies, LLC (Tucson Medical Center), Tucson

04289

Park-Krankenhaus Leipzig GmbH, Leipzig

All Listed Sponsors
lead

Cook Group Incorporated

INDUSTRY

NCT01609621 - Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions | Biotech Hunter | Biotech Hunter